Annual CFF:
-$4.00B+$2.57B(+39.15%)Summary
- As of today, AZN annual cash from financing is -$4.00 billion, with the most recent change of +$2.57 billion (+39.15%) on December 31, 2024.
- During the last 3 years, AZN annual cash from financing has fallen by -$7.64 billion (-209.51%).
- AZN annual cash from financing is now -166.04% below its all-time high of $6.05 billion, reached on December 31, 2007.
Performance
AZN Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFF:
-$2.06B-$2.56B(-510.51%)Summary
- As of today, AZN quarterly cash from financing is -$2.06 billion, with the most recent change of -$2.56 billion (-510.51%) on September 30, 2025.
- Over the past year, AZN quarterly cash from financing has increased by +$2.07 billion (+50.19%).
- AZN quarterly cash from financing is now -116.83% below its all-time high of $12.23 billion, reached on June 30, 2007.
Performance
AZN Quarterly Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
-$4.93B+$2.07B(+29.59%)Summary
- As of today, AZN TTM cash from financing is -$4.93 billion, with the most recent change of +$2.07 billion (+29.59%) on September 30, 2025.
- Over the past year, AZN TTM cash from financing has dropped by -$1.32 billion (-36.46%).
- AZN TTM cash from financing is now -172.69% below its all-time high of $6.79 billion, reached on March 31, 2008.
Performance
AZN TTM Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
AZN Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +39.1% | +50.2% | -36.5% |
| 3Y3 Years | -209.5% | -43.9% | +33.0% |
| 5Y5 Years | -126.4% | -265.5% | -10000.0% |
AZN Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -209.5% | +41.4% | -201.4% | +50.2% | -123.2% | +43.5% |
| 5Y | 5-Year | -209.5% | +41.4% | -128.2% | +50.2% | -229.9% | +43.5% |
| All-Time | All-Time | -166.0% | +57.1% | -116.8% | +50.2% | -172.7% | +48.4% |
AZN Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$2.06B(-510.5%) | -$4.93B(+29.6%) |
| Jun 2025 | - | $501.20M(+118.5%) | -$7.01B(+19.7%) |
| Mar 2025 | - | -$2.71B(-303.4%) | -$8.73B(-118.5%) |
| Dec 2024 | -$4.00B(+39.2%) | -$671.00M(+83.8%) | -$4.00B(-10.5%) |
| Sep 2024 | - | -$4.13B(-238.1%) | -$3.62B(-63.5%) |
| Jun 2024 | - | -$1.22B(-160.3%) | -$2.21B(+11.8%) |
| Mar 2024 | - | $2.03B(+796.9%) | -$2.51B(+61.8%) |
| Dec 2023 | -$6.57B(+3.8%) | -$291.00M(+89.3%) | -$6.57B(+1.0%) |
| Sep 2023 | - | -$2.73B(-79.5%) | -$6.63B(-24.3%) |
| Jun 2023 | - | -$1.52B(+25.2%) | -$5.34B(-4.4%) |
| Mar 2023 | - | -$2.03B(-467.3%) | -$5.11B(+25.0%) |
| Dec 2022 | -$6.82B(-287.0%) | -$358.00M(+75.0%) | -$6.82B(+7.4%) |
| Sep 2022 | - | -$1.43B(-10.4%) | -$7.37B(-27.1%) |
| Jun 2022 | - | -$1.29B(+65.4%) | -$5.79B(-307.8%) |
| Mar 2022 | - | -$3.74B(-314.6%) | $2.79B(-26.6%) |
| Dec 2021 | $3.65B(+265.6%) | -$902.00M(-735.2%) | $3.80B(+52.5%) |
| Sep 2021 | - | $142.00M(-98.1%) | $2.49B(-30.7%) |
| Jun 2021 | - | $7.29B(+366.9%) | $3.59B(+239.6%) |
| Mar 2021 | - | -$2.73B(-23.6%) | -$2.57B(-16.7%) |
| Dec 2020 | -$2.20B(-24.8%) | -$2.21B(-277.8%) | -$2.20B(>-9900.0%) |
| Sep 2020 | - | $1.24B(+10.4%) | $13.00M(+100.3%) |
| Jun 2020 | - | $1.13B(+147.7%) | -$3.94B(-15.0%) |
| Mar 2020 | - | -$2.36B(>-9900.0%) | -$3.43B(-94.3%) |
| Dec 2019 | -$1.76B(+13.6%) | $6.00M(+100.2%) | -$1.76B(+49.6%) |
| Sep 2019 | - | -$2.71B(-265.5%) | -$3.50B(-463.2%) |
| Jun 2019 | - | $1.64B(+334.8%) | -$622.00M(+70.1%) |
| Mar 2019 | - | -$698.00M(+59.7%) | -$2.08B(-1.5%) |
| Dec 2018 | -$2.04B(+30.4%) | -$1.73B(-1124.9%) | -$2.05B(-523.7%) |
| Sep 2018 | - | $169.00M(-7.1%) | -$328.44M(+90.8%) |
| Jun 2018 | - | $182.00M(+127.3%) | -$3.57B(-128.5%) |
| Mar 2018 | - | -$667.44M(-5462.0%) | -$1.56B(+46.8%) |
| Dec 2017 | -$2.94B(-121.8%) | -$12.00M(+99.6%) | -$2.94B(+9.0%) |
| Sep 2017 | - | -$3.07B(-240.3%) | -$3.23B(-178.4%) |
| Jun 2017 | - | $2.19B(+207.1%) | -$1.16B(+42.2%) |
| Mar 2017 | - | -$2.04B(-571.7%) | -$2.01B(-52.9%) |
| Dec 2016 | -$1.32B(-250.8%) | -$304.00M(+69.7%) | -$1.31B(-140.0%) |
| Sep 2016 | - | -$1.00B(-174.7%) | $3.28B(+0.5%) |
| Jun 2016 | - | $1.34B(+199.6%) | $3.26B(+55.3%) |
| Mar 2016 | - | -$1.35B(-131.5%) | $2.10B(+139.1%) |
| Dec 2015 | $878.00M(+132.5%) | $4.28B(+520.8%) | $878.00M(+139.1%) |
| Sep 2015 | - | -$1.02B(-662.4%) | -$2.24B(+10.6%) |
| Jun 2015 | - | $181.00M(+107.0%) | -$2.51B(+17.7%) |
| Mar 2015 | - | -$2.57B(-321.3%) | -$3.05B(-12.8%) |
| Dec 2014 | -$2.71B(+11.2%) | $1.16B(+190.4%) | -$2.70B(+26.5%) |
| Sep 2014 | - | -$1.28B(-255.9%) | -$3.68B(-4.7%) |
| Jun 2014 | - | -$360.69M(+83.8%) | -$3.51B(-14.6%) |
| Mar 2014 | - | -$2.22B(-1285.9%) | -$3.07B(-1.1%) |
| Dec 2013 | -$3.05B(+38.1%) | $187.33M(+116.8%) | -$3.03B(+19.5%) |
| Sep 2013 | - | -$1.12B(-1379.0%) | -$3.77B(-29.5%) |
| Jun 2013 | - | $87.43M(+104.0%) | -$2.91B(+22.0%) |
| Mar 2013 | - | -$2.19B(-300.4%) | -$3.73B(+24.6%) |
| Dec 2012 | -$4.92B(+47.2%) | -$546.59M(-110.3%) | -$4.95B(+18.1%) |
| Sep 2012 | - | -$259.91M(+64.6%) | -$6.04B(+29.6%) |
| Jun 2012 | - | -$734.07M(+78.5%) | -$8.58B(+2.4%) |
| Mar 2012 | - | -$3.41B(-107.6%) | -$8.79B(+5.6%) |
| Dec 2011 | -$9.32B | -$1.64B(+41.3%) | -$9.31B(+2.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2011 | - | -$2.80B(-196.9%) | -$9.56B(-11.2%) |
| Jun 2011 | - | -$942.00M(+76.0%) | -$8.60B(-5.9%) |
| Mar 2011 | - | -$3.93B(-107.4%) | -$8.12B(-12.2%) |
| Dec 2010 | -$7.33B(-102.1%) | -$1.89B(-3.3%) | -$7.23B(-34.9%) |
| Sep 2010 | - | -$1.83B(-296.7%) | -$5.36B(-8.8%) |
| Jun 2010 | - | -$462.35M(+84.8%) | -$4.93B(-7.1%) |
| Mar 2010 | - | -$3.04B(>-9900.0%) | -$4.60B(-25.1%) |
| Dec 2009 | -$3.63B(+43.0%) | -$24.03M(+98.3%) | -$3.68B(+30.2%) |
| Sep 2009 | - | -$1.40B(-933.2%) | -$5.27B(+12.7%) |
| Jun 2009 | - | -$135.74M(+93.6%) | -$6.04B(+1.3%) |
| Mar 2009 | - | -$2.12B(-31.1%) | -$6.12B(+4.3%) |
| Dec 2008 | -$6.36B(-205.1%) | -$1.62B(+25.6%) | -$6.39B(-30.1%) |
| Sep 2008 | - | -$2.17B(-922.5%) | -$4.92B(+13.0%) |
| Jun 2008 | - | -$212.40M(+91.1%) | -$5.65B(-183.3%) |
| Mar 2008 | - | -$2.39B(-1648.1%) | $6.79B(+11.7%) |
| Dec 2007 | $6.05B(+212.8%) | -$137.00M(+95.3%) | $6.08B(+19.2%) |
| Sep 2007 | - | -$2.91B(-123.8%) | $5.10B(-16.4%) |
| Jun 2007 | - | $12.23B(+493.7%) | $6.10B(+189.6%) |
| Mar 2007 | - | -$3.11B(-178.8%) | -$6.81B(-27.5%) |
| Dec 2006 | -$5.37B(-17.4%) | -$1.11B(+41.7%) | -$5.34B(-5.9%) |
| Sep 2006 | - | -$1.91B(-182.7%) | -$5.04B(-7.0%) |
| Jun 2006 | - | -$675.60M(+58.7%) | -$4.71B(-0.7%) |
| Mar 2006 | - | -$1.64B(-100.8%) | -$4.67B(-1.0%) |
| Dec 2005 | -$4.57B(-65.6%) | -$814.78M(+48.5%) | -$4.63B(-4.0%) |
| Sep 2005 | - | -$1.58B(-146.6%) | -$4.45B(-14.2%) |
| Jun 2005 | - | -$641.58M(+59.6%) | -$3.90B(-4.1%) |
| Mar 2005 | - | -$1.59B(-149.2%) | -$3.74B(-34.7%) |
| Dec 2004 | -$2.76B(-3.3%) | -$637.84M(+38.0%) | -$2.78B(+20.6%) |
| Sep 2004 | - | -$1.03B(-111.0%) | -$3.50B(-54.9%) |
| Jun 2004 | - | -$487.72M(+21.9%) | -$2.26B(+28.9%) |
| Mar 2004 | - | -$624.67M(+54.0%) | -$3.18B(-18.3%) |
| Dec 2003 | -$2.67B(+19.3%) | -$1.36B(-740.8%) | -$2.69B(-24.4%) |
| Sep 2003 | - | $212.00M(+115.1%) | -$2.16B(+10.9%) |
| Jun 2003 | - | -$1.41B(-957.1%) | -$2.42B(+3.5%) |
| Mar 2003 | - | -$132.96M(+84.0%) | -$2.51B(+0.1%) |
| Dec 2002 | -$3.31B(-71.2%) | -$832.53M(-1534.8%) | -$2.51B(-14.4%) |
| Sep 2002 | - | -$50.92M(+96.6%) | -$2.20B(+22.2%) |
| Jun 2002 | - | -$1.49B(-1007.1%) | -$2.82B(-8.1%) |
| Mar 2002 | - | -$135.00M(+73.9%) | -$2.61B(+1.2%) |
| Dec 2001 | -$1.94B(-383.4%) | -$516.96M(+23.7%) | -$2.64B(-20.8%) |
| Sep 2001 | - | -$677.24M(+47.2%) | -$2.19B(-38.8%) |
| Jun 2001 | - | -$1.28B(-665.9%) | -$1.58B(-276.3%) |
| Mar 2001 | - | -$167.46M(-174.9%) | -$418.93M(-4.7%) |
| Dec 2000 | -$400.29M(+75.8%) | -$60.91M(+6.8%) | -$400.29M(-17.9%) |
| Sep 2000 | - | -$65.34M(+47.8%) | -$339.38M(-23.8%) |
| Jun 2000 | - | -$125.23M(+15.8%) | -$274.04M(-84.2%) |
| Mar 2000 | - | -$148.81M | -$148.81M |
| Dec 1999 | -$1.65B(-631.0%) | - | - |
| Dec 1998 | -$226.00M(-327.2%) | - | - |
| Dec 1997 | -$52.90M(+20.8%) | - | - |
| Dec 1996 | -$66.79M(-190.0%) | - | - |
| Dec 1995 | $74.17M(+109.2%) | - | - |
| Dec 1994 | -$805.15M(-219.9%) | - | - |
| Dec 1993 | $671.56M(+638.0%) | - | - |
| Dec 1992 | $91.00M(+134.7%) | - | - |
| Dec 1991 | -$261.97M(+52.8%) | - | - |
| Dec 1990 | -$555.53M | - | - |
FAQ
- What is AstraZeneca PLC annual cash from financing?
- What is the all-time high annual cash from financing for AstraZeneca PLC?
- What is AstraZeneca PLC annual cash from financing year-on-year change?
- What is AstraZeneca PLC quarterly cash from financing?
- What is the all-time high quarterly cash from financing for AstraZeneca PLC?
- What is AstraZeneca PLC quarterly cash from financing year-on-year change?
- What is AstraZeneca PLC TTM cash from financing?
- What is the all-time high TTM cash from financing for AstraZeneca PLC?
- What is AstraZeneca PLC TTM cash from financing year-on-year change?
What is AstraZeneca PLC annual cash from financing?
The current annual cash from financing of AZN is -$4.00B
What is the all-time high annual cash from financing for AstraZeneca PLC?
AstraZeneca PLC all-time high annual cash from financing is $6.05B
What is AstraZeneca PLC annual cash from financing year-on-year change?
Over the past year, AZN annual cash from financing has changed by +$2.57B (+39.15%)
What is AstraZeneca PLC quarterly cash from financing?
The current quarterly cash from financing of AZN is -$2.06B
What is the all-time high quarterly cash from financing for AstraZeneca PLC?
AstraZeneca PLC all-time high quarterly cash from financing is $12.23B
What is AstraZeneca PLC quarterly cash from financing year-on-year change?
Over the past year, AZN quarterly cash from financing has changed by +$2.07B (+50.19%)
What is AstraZeneca PLC TTM cash from financing?
The current TTM cash from financing of AZN is -$4.93B
What is the all-time high TTM cash from financing for AstraZeneca PLC?
AstraZeneca PLC all-time high TTM cash from financing is $6.79B
What is AstraZeneca PLC TTM cash from financing year-on-year change?
Over the past year, AZN TTM cash from financing has changed by -$1.32B (-36.46%)